Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

Damiano Baroncini; Angelo Ghezzi; Clara Guaschino; Lucia Moiola; Massimo Filippi; Antonio Ianniello; Carlo Pozzilli; Roberta Lanzillo; Vincenzo Brescia Morra; Monica Margoni; Paolo Gallo; Graziella Callari; Luigi Maria Edoardo Grimaldi; Giacomo Lus; Massimiliano Calabrese; Marta Simone; Girolama Alessandra Marfia; Sarah Rasia; Daniela Cargnelutti; Giancarlo Comi; Mauro Zaffaroni; María Trojano; Diego Centonze; Ruggero Capra; Marco Capobianco; Alice Laroni; Antonio Uccelli; Antonio Gallo; Francesco Patti; Maura Danni; Claudio Gasperini; G. Coniglio

doi:10.1007/s10072-022-06211-8

Related publications

Article2025

Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience

Alberico L. Catapano, Aldo P. Maggioni, Francesco Rossi, Eleonora Consolo, Lucia Notarianni, Giancarlo Agnelli

Article2017

Long-term follow-up of a child with Klinefelter syndrome and achondroplasia from infancy to 16 years

Jessica D. Arditi, Loretta Thomaidis, Helen Frysira, Artemis Doulgeraki, George Chrousos, Christina Kanaka‐Gantenbein

Article2007

The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study

Luca Roccatagliata, Maria A. Rocca, Paola Valsasina, Laura Bonzano, Maria Pia Sormani, Riccardo Saccardi, Gianluigi Mancardi, Massimo Filippi

Preprint2025

Long-term follow-up after atrioventricular node ablation in patients with atrial fibrillation: A nationwide Danish cohort study

Anders Fyhn Elgaard, Jacob Moesgaard Larsen, P Dinesen, Sam Riahi, Søren Lundbye‐Christensen, Peter Jacobsen, Arne Johannessen, Uffe Jakob Ortved Gang, Steen Buus Kristiansen, Stig Djurhuus, Professor Gregory Lip

Article2021

Long term follow-up in advanced Parkinson’s disease treated with DBS of the subthalamic nucleus

Maria Antonietta Volonté, Giacomo Clarizio, Sebastiano Galantucci, Pietro Giuseppe Scamarcia, Rosalinda Cardamone, Lina Raffaella Barzaghi, Monica Falautano, Pietro Mortini, Gıancarlo Comı, Massimo Filippi

Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

Discussion(0)